Inogen Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
Inogen, Inc. (NASDAQ: INGN), a medical technology firm specializing in respiratory products, announced participation in the 40th Annual J.P. Morgan Healthcare Conference. President and CEO Nabil Shabshab is set to present on January 12, 2022, at 10:30 a.m. PT. The live audio webcast will be accessible via the Investor Relations section of Inogen's website. A replay will be available for 90 days post-event. Inogen continues to utilize its Investor Relations platform for disclosing material non-public information.
- Participation in the prestigious J.P. Morgan Healthcare Conference enhances visibility.
- Live webcast allows broader access to investors and stakeholders.
- None.
Inogen’s President and CEO,
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005005/en/
Investor and Media Contacts
Inogen-SVC@sardverb.com
(312) 895-4700
Source:
FAQ
When is Inogen's presentation at the J.P. Morgan Healthcare Conference?
Where can I access the webcast of Inogen's conference presentation?
What stock symbol does Inogen trade under?
What type of products does Inogen specialize in?